title: A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.
authors.forename: Semih
authors.initials: S
authors.lastname: Tatlican
authors.forename: Cemile
authors.initials: C
authors.lastname: Eren
authors.forename: Damla
authors.initials: D
authors.lastname: Atacan
authors.forename: Umut
authors.initials: U
authors.lastname: Dalgic
authors.forename: Filiz
authors.initials: F
authors.lastname: Canpolat
authors.forename: Fatma
authors.initials: F
authors.lastname: Eskioglu
mesh_terms: D000279:Administration, Cutaneous; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy*; D008875:Middle Aged; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus